Prox Capital Holdings, LLC

BALTIMORE, MD · Founded 2020 · CIK 0001814334 · Biotech

Proximity-controlled molecular therapeutics platform

generalproximity.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$800K
1 Form D · Jun 2020
76 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$800,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1325Senseion Therapeutics, Inc.——
1326Sequegenics LLC——
1327Nellone Therapeutics, Inc.——
1328Prox Capital Holdings, LLC—$800K
1329Parabilis Medicines——
1330Mozart Therapeutics——
1331Knudra Diagnostics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • John AllenExecutive Officer · Promoter
  • Sarah LiebExecutive Officer
  • Adam MarkleyExecutive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.